Across TCGA pan-cancer cohorts, UBE2D3P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of UBE2D3P1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where UBE2D3P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types UBE2D3P1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

HNSC, THCA, and LUAD are the cancer types where UBE2D3P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2D3P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.437	<.001	11	view →
THCA	All	All	−0.293	.001	4	view →
LUAD	Female	All	+0.397	.010	2	view →
COAD	All	II,III,IV	+0.407	.037	1	view →
LIHC	All	All	+0.140	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: UBE2D3P1 RNA expression & survival · all UBE2D3P1 data types